Early data: AI-developed drug rentosertib alters 326 proteins and may slow aging
Dr_Singularity · x · 2026-09-07
Early data on rentosertib, a drug candidate developed with AI's help for a rare lung condition, suggests it may also reduce biological hallmarks of aging:
- The drug altered 326 circulating proteins, with analyses pointing to changes in senescence, metabolism, and other aging-related pathways.
- Exploratory organ-specific clocks suggested younger biological profiles in arteries, brain, pancreas, stomach, and the immune system.
- Findings remain early and need confirmation in larger, independent studies.
More from Research
- scikit-learn 1.9 ships metric_at_thresholds to simplify optimal decision threshold search — GaelVaroquaux · 2026-09-08
- Astra agent inside Codex picks the same cancer sequencing variants a researcher would choose — iskander · 2026-09-08
- Enterprise agent evals need world-first design, not task-first, argues Shahules Anwar — Shahules786 · 2026-09-08
- Ineffable Labs adds six co-founders alongside ex-DeepMind's David Silver — giffmana · 2026-09-08
- Training a 9B model with GRPO to build low-poly Blender rooms: lessons learned — TheMoonMidas · 2026-09-08
- 2026 PNPL competition targets non-invasive speech decoding with MEG — pnpl · 2026-09-08